Fig. 2From: Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimenKaplan-Meier survival curves for overall survival (OS) according to a age-adjusted Charlson Comorbidity Index (ACCI) 4, b body mass index (BMI) 20 kg/m2, c cytogenetic risk, and d international staging system (ISS)Back to article page